Wessel E van der Steen1,2, Eva L Leemans1,3, René van den Berg3, Yvo B W E M Roos2, Henk A Marquering4,5, Dagmar Verbaan6, Charles B L M Majoie3. 1. Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Room L0-106, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. 2. Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 3. Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 4. Department of Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Room L0-106, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. h.a.marquering@amc.uva.nl. 5. Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. h.a.marquering@amc.uva.nl. 6. Neurosurgical Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
PURPOSE: Delayed cerebral ischemia (DCI) is a severe complication of aneurysmal subarachnoid hemorrhage (aSAH). The extent of subarachnoid blood is a strong predictor of DCI and is frequently estimated with the Fisher scale, modified Fisher scale, or Hijdra sum score. It is unclear which scale has the strongest association with clinical DCI. To evaluate this, we performed a systematic review of the literature. METHODS: We performed a MEDLINE and EMBASE search from 1980 to 20th of June 2017. Radiological grade and occurrence of clinical DCI were extracted along with odds ratios (ORs) for DCI. When possible, pooled ORs with 95% confidence intervals were calculated per grade increase on the radiological scale. RESULTS: Fifty-three studies were included. The Fisher scale was significantly associated with DCI in 62% of the studies compared to 88-100% for the other scales. In studies using the Fisher scale, Fisher 3 had the strongest association with DCI (pooled OR 3.21 (1.87-5.49)). In studies using the modified Fisher score, DCI occurred most frequently (42%) in modified Fisher 4. No pooled OR could be calculated for the other scales. CONCLUSION: The Fisher scale, modified Fisher scale, and Hijdra sum score are all associated with clinical DCI. The risk of DCI, however, does not increase with increasing Fisher grade as opposed to the modified Fisher scale. Furthermore, the modified Fisher scale was more commonly significantly associated with DCI than the Fisher scale, which may advocate using the modified Fisher in future SAH-related studies.
PURPOSE:Delayed cerebral ischemia (DCI) is a severe complication of aneurysmal subarachnoid hemorrhage (aSAH). The extent of subarachnoid blood is a strong predictor of DCI and is frequently estimated with the Fisher scale, modified Fisher scale, or Hijdra sum score. It is unclear which scale has the strongest association with clinical DCI. To evaluate this, we performed a systematic review of the literature. METHODS: We performed a MEDLINE and EMBASE search from 1980 to 20th of June 2017. Radiological grade and occurrence of clinical DCI were extracted along with odds ratios (ORs) for DCI. When possible, pooled ORs with 95% confidence intervals were calculated per grade increase on the radiological scale. RESULTS: Fifty-three studies were included. The Fisher scale was significantly associated with DCI in 62% of the studies compared to 88-100% for the other scales. In studies using the Fisher scale, Fisher 3 had the strongest association with DCI (pooled OR 3.21 (1.87-5.49)). In studies using the modified Fisher score, DCI occurred most frequently (42%) in modified Fisher 4. No pooled OR could be calculated for the other scales. CONCLUSION: The Fisher scale, modified Fisher scale, and Hijdra sum score are all associated with clinical DCI. The risk of DCI, however, does not increase with increasing Fisher grade as opposed to the modified Fisher scale. Furthermore, the modified Fisher scale was more commonly significantly associated with DCI than the Fisher scale, which may advocate using the modified Fisher in future SAH-related studies.
Authors: C Charpentier; G Audibert; F Guillemin; T Civit; X Ducrocq; S Bracard; H Hepner; L Picard; M C Laxenaire Journal: Stroke Date: 1999-07 Impact factor: 7.914
Authors: Y B Roos; R J de Haan; L F Beenen; R J Groen; K W Albrecht; M Vermeulen Journal: J Neurol Neurosurg Psychiatry Date: 2000-03 Impact factor: 10.154
Authors: J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: Brian L Hoh; Mehmet A Topcuoglu; Aneesh B Singhal; Johnny C Pryor; James D Rabinov; Guy A Rordorf; Bob S Carter; Christopher S Ogilvy Journal: Neurosurgery Date: 2004-10 Impact factor: 4.654
Authors: Matthew J McGirt; John C Mavropoulos; Laura Y McGirt; Michael J Alexander; Allan H Friedman; Daniel T Laskowitz; John R Lynch Journal: J Neurosurg Date: 2003-06 Impact factor: 5.115
Authors: Amir R Dehdashti; Bernadette Mermillod; Daniel A Rufenacht; Alain Reverdin; Nicolas de Tribolet Journal: Cerebrovasc Dis Date: 2003-10-03 Impact factor: 2.762
Authors: Eric M Liotta; Ameeta Karmarkar; Ayush Batra; Minjee Kim; Shyam Prabhakaran; Andrew M Naidech; Matthew B Maas Journal: Crit Care Med Date: 2020-01 Impact factor: 7.598
Authors: Oliver Richards; Kirsten J Cromie; Christopher Akhunbay-Fudge; Neeraj Kalra; Richard G Feltbower; Paul Chumas; Ian A Anderson Journal: Acta Neurochir (Wien) Date: 2022-01-18 Impact factor: 2.216
Authors: Hsin Yi Chen; Jonathan Elmer; Sahar F Zafar; Manohar Ghanta; Valdery Moura Junior; Eric S Rosenthal; Emily J Gilmore; Lawrence J Hirsch; Hitten P Zaveri; Kevin N Sheth; Nils H Petersen; M Brandon Westover; Jennifer A Kim Journal: Neurology Date: 2021-11-29 Impact factor: 9.910
Authors: Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald Journal: Transl Stroke Res Date: 2020-10-19 Impact factor: 6.829